Yahoo Web Search

Search results

1. Movies & TV Shows

   • • 

       The A-Team

       1983
     • 

       NYPD Blue

       1993
     • 

       L.A. Law

       1986
     • 

       Cagney & Lacey

       1981
     • 

       Suddenly Susan

       1996
     • 

       Scarecrow and Mrs. King

       1983

   Show more

2. www.imdb.com › name › nm0399030Pearl Huang - IMDb

   www.imdb.com › name › nm0399030

   • Cached

   Pearl Huang is known for Corrina, Corrina (1994), Cherry 2000 (1987) and Suddenly Susan (1996). She was previously married to James Hong.

3. www.dunadtx.com › our-biosOur Bios | Dunad Therapeutics

   www.dunadtx.com › our-bios

   • Cached

   Pearl Huang, Ph.D., has more than 30 years of leadership experience in pharma and biotech and is now the President and CEO of Dunad Therapeutics. Pearl earned a bachelor’s degree in biology from MIT and went on to complete her PhD in molecular biology from Princeton University.

4. www.biospace.com › article › dr-pearl-huang-named-ceo-of-novartis-backed-dunadDr. Pearl Huang Named CEO of Novartis-Backed Dunad ... - BioSpace

   www.biospace.com › article › dr-pearl-huang-named-ceo-of-novartis-backed-dunad

   • Cached

   Jun 28, 2022 · Pearl Huang, Ph.D., has more than 20 years of leadership experience in pharma and biotech, and she just added a new line to her resume. Dr. Huang is now the CEO of Dunad Therapeutics, a Novartis -backed biopharmaceutical startup.

5. www.imdb.com › name › nm0399030Pearl Huang - Biography - IMDb

   www.imdb.com › name › nm0399030

   • Cached

   Pearl Huang is known for Corrina, Corrina (1994), Cherry 2000 (1987) and Suddenly Susan (1996). She was previously married to James Hong.

6. www.linkedin.com › in › pearl-huang-1916664Pearl Huang - Dunad Therapeutics | LinkedIn

   www.linkedin.com › in › pearl-huang-1916664

   View Pearl Huang’s profile on LinkedIn, a professional community of 1 billion members.

   • Location: Dunad Therapeutics

7. news.mit.edu › 2021 › corporation-11-term-three-life-members-0603MIT Corporation elects 11 term members, three life members

   news.mit.edu › 2021 › corporation-11-term-three-life-members-0603

   • Cached

   Jun 3, 2021 · Pearl Huang, president and CEO, Cygnal Therapeutics. Huang earned a bachelor’s degree in biology from MIT in 1980 and a PhD in molecular biology from Princeton University in 1990. Huang began her career at Merck Research Labs in 1990 before moving to DuPont Pharmaceuticals as the director of cancer biology.

8. corporation.mit.edu › all-members › pearl-s-huangPearl S. Huang | The MIT Corporation

   corporation.mit.edu › all-members › pearl-s-huang

   • Cached

   Pearl S. Huang ’80. Member 2021-26. President and Chief Executive Officer Cygnal Therapeutics, Inc. Cambridge, Massachusetts

9. endpts.com › longtime-biotech-leader-pearl-huang-takes-the-reigns-as-ceo-ofLongtime biotech leader Pearl Huang takes the reins as CEO of...

   endpts.com › longtime-biotech-leader-pearl-huang-takes-the-reigns-as-ceo-of

   • Cached

   Jun 28, 2022 · Long­time biotech leader Pearl Huang takes the reins as CEO of No­var­tis-backed up­start. Tyler Patchen. News Reporter. It has on­ly been a few months since Pearl Huang ex­it­ed the top...

10. www.fiercebiotech.com › biotech › flagship-names-ex-roche-svp-as-ceo-cancerFlagship names ex-Roche SVP as CEO of cancer startup Cygnal

    www.fiercebiotech.com › biotech › flagship-names-ex-roche-svp-as-ceo-cancer

    • Cached

    Jan 11, 2019 · Cygnal Therapeutics has named Pearl Huang as CEO. The ex-Roche senior vice president and Beigene founder will lead the Flagship Pioneering startup as it builds a pipeline of cancer drugs...

11. www.dunadtx.com › post › dunad-therapeutics-appoints-industry-veteran-pearl-huangDunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief...

    www.dunadtx.com › post › dunad-therapeutics-appoints-industry-veteran-pearl-huang

    • Cached

    CAMBRIDGE, England, June 28, 2022 – Dunad Therapeutics, a biopharmaceutical company developing small molecule covalent therapies based on novel insights from chemistry and protein degradation, today announced it has appointed Pearl Huang, Ph.D., as Chief Executive Officer.